Home›Stock Screener›Mankind Pharma›Shareholding Pattern

Mankind Pharma Shareholding Pattern

As of Mar 2026, Mankind Pharma (MANKIND) promoter holding 72.66%, FII 10.24%, DII 14.46%, public 1.39%, total shareholders 177,606. Browse MANKIND cash flow statement for revenue, profit, balance sheet and cash flow data.

Promoter Holding 72.66%
FII Holding 10.24%
DII Holding 14.46%
Public Holding 1.39%
Total Shareholders 177,606
As of Mar 2026

MANKIND Recent Shareholding Changes — Promoter, FII & DII

Mankind Pharma promoter, FII and DII holding change from Dec 2025 to Mar 2026, FII -1.1%, DII +1.21%. Explore MANKIND fundamental worth to estimate fundamental worth using multiple valuation models.

Promoter Holding Change
Dec 2025 to Mar 2026
No Change
FII Holding Change
Dec 2025 to Mar 2026
-1.1%
DII Holding Change
Dec 2025 to Mar 2026
+1.21%
Public Holding Change
Dec 2025 to Mar 2026
-0.13%

Mankind Pharma Quarterly Shareholding Trend — Promoter, FII, DII & Public

MANKIND promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. For live price, key ratios and the full company profile, see MANKIND screener.

Promoter
FII
DII
Public
Government

MANKIND Shareholding Pattern Data — Quarterly History

Mankind Pharma quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 72.66% 10.24% 14.46% 0.00% 1.39% 1.25% 100.00% 177,606
Dec 2025 72.66% 11.34% 13.25% 0.00% 1.52% 1.23% 100.00% 177,539
Sept 2025 72.67% 12.84% 11.92% 0.00% 1.36% 1.21% 100.00% 170,347
Jun 2025 72.68% 13.07% 11.50% 0.00% 1.52% 1.23% 100.00% 179,549
Mar 2025 72.70% 12.92% 11.48% 0.00% 1.64% 1.26% 100.00% 180,597
Dec 2024 72.71% 13.34% 11.06% 0.00% 1.60% 1.30% 100.01% 172,431
Sept 2024 74.87% 12.37% 9.90% 0.00% 1.55% 1.31% 100.00% 163,854
Jun 2024 74.87% 11.58% 9.95% 0.00% 1.46% 2.15% 100.01% 153,450
Mar 2024 74.88% 9.87% 11.14% 0.00% 1.22% 2.89% 100.00% 135,116
Dec 2023 76.50% 0.00% 9.49% 0.00% 1.14% 12.87% 100.00% 127,449
Sept 2023 76.50% 0.00% 4.39% 0.00% 1.11% 18.00% 100.00% 134,731
Jun 2023 76.50% 0.00% 4.64% 0.00% 1.02% 17.83% 99.99% 131,918
May 2023 76.50% 0.00% 2.64% 0.00% 4.15% 16.71% 100.00% 402,322
Mar 2023 76.50% 0.00% 2.64% 0.00% 4.15% 16.71% 100.00% 402,322
Sept 2022 79.00% 0.00% 0.00% 0.00% 0.00% 21.00% 100.00% 17
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 72.66% 10.24% 14.46% 0.00% 1.39% 1.25% 100.00% 177,606
Dec 2025 72.66% 11.34% 13.25% 0.00% 1.52% 1.23% 100.00% 177,539
Sept 2025 72.67% 12.84% 11.92% 0.00% 1.36% 1.21% 100.00% 170,347
Jun 2025 72.68% 13.07% 11.50% 0.00% 1.52% 1.23% 100.00% 179,549
Mar 2025 72.70% 12.92% 11.48% 0.00% 1.64% 1.26% 100.00% 180,597
Dec 2024 72.71% 13.34% 11.06% 0.00% 1.60% 1.30% 100.01% 172,431
Sept 2024 74.87% 12.37% 9.90% 0.00% 1.55% 1.31% 100.00% 163,854
Jun 2024 74.87% 11.58% 9.95% 0.00% 1.46% 2.15% 100.01% 153,450
Mar 2024 74.88% 9.87% 11.14% 0.00% 1.22% 2.89% 100.00% 135,116
Dec 2023 76.50% 0.00% 9.49% 0.00% 1.14% 12.87% 100.00% 127,449
Sept 2023 76.50% 0.00% 4.39% 0.00% 1.11% 18.00% 100.00% 134,731
Jun 2023 76.50% 0.00% 4.64% 0.00% 1.02% 17.83% 99.99% 131,918
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 72.66% 10.24% 14.46% 0.00% 1.39% 1.25% 100.00% 177,606
Dec 2025 72.66% 11.34% 13.25% 0.00% 1.52% 1.23% 100.00% 177,539
Dec 2024 72.71% 13.34% 11.06% 0.00% 1.60% 1.30% 100.01% 172,431
Dec 2023 76.50% 0.00% 9.49% 0.00% 1.14% 12.87% 100.00% 127,449